PAR 2.38% 20.5¢ paradigm biopharmaceuticals limited..

Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,149 Posts.
    lightbulb Created with Sketch. 581
    You're 100% correct.

    I wanted topline readout results from the 008 study tomorrow. Because they promised it yesterday (Q3 2021) and only today they are telling me the trial is over double length of duration because they mismanaged it.

    I'll give you that.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
-0.005(2.38%)
Mkt cap ! $71.73M
Open High Low Value Volume
21.0¢ 21.0¢ 19.5¢ $323.1K 1.612M

Buyers (Bids)

No. Vol. Price($)
1 324 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 52928 5
View Market Depth
Last trade - 16.10pm 28/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.